GI360 Complete x1 day
Innovative, comprehensive and clinically-applicable stool profile, utilizing multiplex PCR molecular technology coupled with growth-based culture and ID by MALDI-TOF, sensitive biochemical assays and microscopy.Note:Calprotectin Improvements in processing technologies have been implemented resulting in reference range adjustments.Care should be taken when using historical values with the predicate method for serial monitoring because new values are higherElastaseReference ranges remain unchanged, however improved analysis is showing fewer low range results. Comparative of patients previous tests reports should be done with cogniscance of this.Beta-glucuronidaseThe new methodology units, reported values, and reference intervals will change as the method does run higher than the previous method. This method is expected to be more sensitive in identifying elevated beta-glucuronidase values, and is expected to respond (i.e. show lower values) due to effective treatment aimed at inhibiting beta-glucuronidase function in the gut. Clinicians should establish new patient baseline beta-glucuronidase values with the current methodology and should not rely on predicate method for serial monitoring.